Pancreatic Cancer Research

ResearcherTohoku UniversityNo recent work listed

Ming‐xin Cao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4315-7131; OpenAlex author ID A5026314377. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper

Papers 2

  1. Ral GTPase promotes metastasis of pancreatic ductal adenocarcinoma via elevation of TGF-β1 production. Co-author DOI 10.1016/j.jbc.2023.104754↗
  2. Ral GTPase-activating protein regulates the malignancy of pancreatic ductal adenocarcinoma. Co-author DOI 10.1111/cas.14970↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shingo Yoshimachi · 2 shared papers, 2021–2023 · strength 0.27
  2. Hisanori Horiuchi · 2 shared papers, 2021–2023 · strength 0.27
  3. Michiaki Unno · 2 shared papers, 2021–2023 · strength 0.27
  4. Kento Miyazaki · 1 shared paper, 2021 · strength 0.11
  5. Shimpei Maeda · 1 shared paper, 2021 · strength 0.11
  6. Kyohei Ariake · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.